1887

Abstract

is a diverse virulent synthesis pathogen responsible for invasive systemic infections. Establishment of antibiotic resistance in the pathogen has produced a need for new antibiofilm agents to control the biofilm formation and reduce biofilm-associated resistance development.

The present study investigates the antibiofilm activity of eucalyptol against .

The antibiofilm potential of eucalyptol was assessed using a microdilution method and their biofilm inhibition efficacy was visualized by microscopic analysis. The biochemical assays were performed to assess the influence of eucalyptol on virulence productions. Real-time PCR analysis was performed to evaluate the expression profile of the virulence genes.

Eucalyptol showed significant antibiofilm potential in a dose-dependent manner without affecting bacterial growth. Eucalyptol at 300 µg ml (biofilm inhibitory concentration) significantly inhibited the initial stage of biofilm formation in . However, eucalyptol failed to diminish the mature biofilms of at biofilm inhibitory concentration and it effectively reduced the biofilm formation on stainless steel, titanium, and silicone surfaces. The biochemical assay results revealed that eucalyptol greatly affects the cell-surface hydrophobicity, auto-aggregation, extracellular protease, haemolysis and hyaluronic acid synthesis. Further, the gene-expression analysis results showed significant downregulation of virulence gene expression upon eucalyptol treatment.

The present study suggests that eucalyptol applies its antibiofilm assets by intruding the initial biofilm formation of . Supplementary studies are needed to understand the mode of action involved in biofilm inhibition.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.001253
2020-09-15
2024-03-29
Loading full text...

Full text loading...

/deliver/fulltext/jmm/69/11/1308.html?itemId=/content/journal/jmm/10.1099/jmm.0.001253&mimeType=html&fmt=ahah

References

  1. Henningham A, Barnett TC, Maamary PG, Walker MJ. Pathogenesis of group A streptococcal infections. Discov Med 2012; 13:329–342[PubMed]
    [Google Scholar]
  2. World Health Organization The current evidence for the burden of group A Streptococcal diseases. World Health organization; 2005
  3. Ayer V, Tewodros W, Manoharan A, Skariah S, Luo F et al. Tetracycline resistance in group A streptococci: emergence on a global scale and influence on multiple-drug resistance. Antimicrob Agents Chemother 2007; 51:1865–1868 [View Article][PubMed]
    [Google Scholar]
  4. Montes M, Tamayo E, Orden B, Larruskain J, Perez-Trallero E. Prevalence and clonal characterization of Streptococcus pyogenes clinical isolates with reduced fluoroquinolone susceptibility in Spain. Antimicrob Agents Chemother 2010; 54:93–97 [View Article][PubMed]
    [Google Scholar]
  5. Yang P, Peng X, Zhang D, Wu S, Liu Y et al. Characteristics of group A Streptococcus strains circulating during scarlet fever epidemic, Beijing, China, 2011. Emerg Infect Dis 2013; 19:909–915 [View Article][PubMed]
    [Google Scholar]
  6. Adebanjo T, Mosites E, Van Beneden CA, Onukwube J, Blum M et al. Risk factors for group A Streptococcus colonization during an outbreak among people experiencing homelessness in Anchorage, Alaska, 2017. Clin Infect Dis 2017; 67:1784–1787
    [Google Scholar]
  7. Nanduri SA, Metcalf BJ, Arwady MA, Edens C, Lavin MA et al. Prolonged and large outbreak of invasive group A Streptococcus disease within a nursing home: repeated intrafacility transmission of a single strain. Clin Microbiol Infect 2019; 25:248.e1–24248 [View Article][PubMed]
    [Google Scholar]
  8. Hall-Stoodley L, Costerton JW, Stoodley P. Bacterial biofilms: from the natural environment to infectious diseases. Nat Rev Microbiol 2004; 2:95–108 [View Article][PubMed]
    [Google Scholar]
  9. Flemming H-C. EPS—Then and now. Microorganisms 2016; 4:41 [View Article]
    [Google Scholar]
  10. Wolfmeier H, Pletzer D, Mansour SC, Hancock REW. New perspectives in biofilm eradication. ACS Infect Dis 2018; 4:93–106 [View Article][PubMed]
    [Google Scholar]
  11. Krzyściak W, Pluskwa KK, Jurczak A, Kościelniak D. The pathogenicity of the Streptococcus genus. Eur J Clin Microbiol Infect Dis 2013; 32:1361–1376 [View Article][PubMed]
    [Google Scholar]
  12. Fiedler T, Köller T, Kreikemeyer B. Streptococcus pyogenes biofilms-formation, biology, and clinical relevance. Front Cell Infect Microbiol 2015; 5:15 [View Article][PubMed]
    [Google Scholar]
  13. Subramenium GA, Vijayakumar K, Pandian SK. Limonene inhibits streptococcal biofilm formation by targeting surface-associated virulence factors. J Med Microbiol 2015; 64:879–890 [View Article][PubMed]
    [Google Scholar]
  14. Viszwapriya D, Subramenium GA, Prithika U, Balamurugan K, Pandian SK. Betulin inhibits virulence and biofilm of Streptococcus pyogenes by suppressing ropB core regulon, sagA and dltA . Pathog Dis 2016; 74:088 [View Article][PubMed]
    [Google Scholar]
  15. Vijayakumar K, Ramanathan T. Antiquorum sensing and biofilm potential of 5- Hydroxymethylfurfural against Gram positive pathogens. Microb Pathog 2018; 125:48–50 [View Article][PubMed]
    [Google Scholar]
  16. Göbel H, Schmidt G, Dworschak M, Stolze H, Heuss D, Heiiss D. Essential plant oils and headache mechanisms. Phytomedicine 1995; 2:93–102 [View Article][PubMed]
    [Google Scholar]
  17. Aggarwal KK, Tripathi AK, Prajapati V, Kumar S. Toxicity of 1,8-cineole towards three species of stored product coleopterans. Int J Trop Insect Sci 2001; 21:155–160 [View Article]
    [Google Scholar]
  18. Silva SM, Abe SY, Murakami FS, Frensch G, Marques FA et al. Essential oils from different plant parts of Eucalyptus cinerea f. Muell. ex Benth. (Myrtaceae) as a source of 1,8-cineole and their bioactivities. Pharmaceuticals 2011; 4:1535–1550 [View Article][PubMed]
    [Google Scholar]
  19. Padalia RC, Verma RS, Chauhan A, Goswami P, Verma SK et al. Chemical composition of Melaleuca linarrifolia Sm. from India: a potential source of 1,8-cineole. Ind Crops Prod 2015; 63:264–268 [View Article]
    [Google Scholar]
  20. Sfara V, Zerba EN, Alzogaray RA. Fumigant insecticidal activity and repellent effect of five essential oils and seven monoterpenes on first-instar nymphs of Rhodnius prolixus . J Med Entomol 2009; 46:511–515 [View Article][PubMed]
    [Google Scholar]
  21. Rocha Caldas GF, Oliveira ARdaS, Araújo AV, Lafayette SSL, Albuquerque GS et al. Gastroprotective mechanisms of the monoterpene 1,8-cineole (eucalyptol). PLoS One 2015; 10:e0134558–7 [View Article]
    [Google Scholar]
  22. Juergens UR, Dethlefsen U, Steinkamp G, Gillissen A, Repges R et al. Anti-inflammatory activity of 1.8-cineol (eucalyptol) in bronchial asthma: a double-blind placebo-controlled trial. Respir Med 2003; 97:250–256 [View Article][PubMed]
    [Google Scholar]
  23. Shukla R, Singh P, Prakash B, Dubey NK. Antifungal, aflatoxin inhibition and antioxidant activity of Callistemon lanceolatus (Sm.) sweet essential oil and its major component 1,8-cineole against fungal isolates from chickpea seeds. Food Control 2012; 25:27–33 [View Article]
    [Google Scholar]
  24. Merghni A, Noumi E, Hadded O, Dridi N, Panwar H et al. Assessment of the antibiofilm and antiquorum sensing activities of Eucalyptus globulus essential oil and its main component 1,8-cineole against methicillin-resistant Staphylococcus aureus strains. Microb Pathog 2018; 118:74–80 [View Article][PubMed]
    [Google Scholar]
  25. Cox KH, Ruiz-Bustos E, Courtney HS, Dale JB, Pence MA et al. Inactivation of DltA modulates virulence factor expression in Streptococcus pyogenes. PLoS One 2009; 4:e5366 [View Article][PubMed]
    [Google Scholar]
  26. Karuppiah V, Thiruganasambandam R. Anti-biofilm and quorum sensing inhibitory potential of Acanthus ilicifolius against Uropathogens. Int Jrnl Life Sci 2018; 7:65–74 [View Article]
    [Google Scholar]
  27. Sivaranjani M, Srinivasan R, Aravindraja C, Karutha Pandian S, Veera Ravi A. Inhibitory effect of α-mangostin on Acinetobacter baumannii biofilms - an in vitro study. Biofouling 2018; 34:579–593 [View Article][PubMed]
    [Google Scholar]
  28. Kannappan A, Sivaranjani M, Srinivasan R, Rathna J, Pandian SK et al. Inhibitory efficacy of geraniol on biofilm formation and development of adaptive resistance in Staphylococcus epidermidis RP62A. J Med Microbiol 2017; 66:1506–1515 [View Article][PubMed]
    [Google Scholar]
  29. Karuppiah V, Thiruganasambandam R. Antibiofilm and quorum sensing inhibitory potential of Excoecaria agallocha against Pseudomonas aeruginosa . Int J Sci Invent Today 2017; 6:758–771
    [Google Scholar]
  30. Chang Y, Gu W, McLandsborough L. Low concentration of ethylenediaminetetraacetic acid (EDTA) affects biofilm formation of Listeria monocytogenes by inhibiting its initial adherence. Food Microbiol 2012; 29:10–17 [View Article][PubMed]
    [Google Scholar]
  31. Limsuwan S, Voravuthikunchai SP. Boesenbergia pandurata (Roxb.) Schltr., Eleutherine americana Merr. and Rhodomyrtus tomentosa (Aiton) Hassk. as antibiofilm producing and antiquorum sensing in Streptococcus pyogenes. FEMS Immunol Med Microbiol 2008; 53:429–436 [View Article][PubMed]
    [Google Scholar]
  32. Oliver-Kozup H, Martin KH, Schwegler-Berry D, Green BJ, Betts C et al. The group A streptococcal collagen-like protein-1, Scl1, mediates biofilm formation by targeting the extra domain A-containing variant of cellular fibronectin expressed in wounded tissue. Mol Microbiol 2013; 87:672–689 [View Article][PubMed]
    [Google Scholar]
  33. Kos BV, Vuković S, Simpraga M, Frece J et al. Adhesion and aggregation ability of probiotic strain Lactobacillus acidophilus M92. J Appl Microbiol 2003; 94:981–987 [View Article][PubMed]
    [Google Scholar]
  34. Karuppiah V, Thirunanasambandham R. Quebrachitol from Rhizophora mucronata inhibits biofilm formation and virulence production in Staphylococcus epidermidis by impairment of initial attachment and intercellular adhesion. Arch Microbiol 20201–4
    [Google Scholar]
  35. Shafreen RM, Srinivasan S, Manisankar P, Pandian SK. Biofilm formation by Streptococcus pyogenes: modulation of exopolysaccharide by fluoroquinolone derivatives. J Biosci Bioeng 2011; 112:345–350 [View Article][PubMed]
    [Google Scholar]
  36. Hollands A, Aziz RK, Kansal R, Kotb M, Nizet V et al. A naturally occurring mutation in ropB suppresses SpeB expression and reduces M1T1 group A streptococcal systemic virulence. PLoS One 2008; 3:e4102 [View Article][PubMed]
    [Google Scholar]
  37. Oh ET, So J-S. A rapid method for RNA preparation from Gram-positive bacteria. J Microbiol Methods 2003; 52:395–398 [View Article][PubMed]
    [Google Scholar]
  38. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2− ΔΔCT method. Methods 2001; 25:402–408 [View Article][PubMed]
    [Google Scholar]
  39. Hughes G, Webber MA. Novel approaches to the treatment of bacterial biofilm infections. Br J Pharmacol 2017; 174:2237–2246 [View Article][PubMed]
    [Google Scholar]
  40. Hendry ER, Worthington T, Conway BR, Lambert PA. Antimicrobial efficacy of Eucalyptus oil and 1,8-cineole alone and in combination with chlorhexidine digluconate against microorganisms grown in planktonic and biofilm cultures. J Antimicrob Chemother 2009; 64:1219–1225 [View Article][PubMed]
    [Google Scholar]
  41. Gotman I. Characteristics of metals used in implants. J Endourol 1997; 11:383–389 [View Article][PubMed]
    [Google Scholar]
  42. Donlan RM. Biofilms: microbial life on surfaces. Emerg Infect Dis 2002; 8:881–890 [View Article][PubMed]
    [Google Scholar]
  43. Nithyanand P, Thenmozhi R, Rathna J, Pandian SK. Inhibition of Streptococcus pyogenes biofilm formation by coral-associated actinomycetes. Curr Microbiol 2010; 60:454–460 [View Article][PubMed]
    [Google Scholar]
  44. Courtney HS, Ofek I, Penfound T, Nizet V, Pence MA et al. Relationship between expression of the family of M proteins and lipoteichoic acid to hydrophobicity and biofilm formation in Streptococcus pyogenes. PLoS One 2009; 4:1–10 [View Article][PubMed]
    [Google Scholar]
  45. Gross M, Cramton SE, Götz F, Peschel A. Key role of teichoic acid net charge in Staphylococcus aureus colonization of artificial surfaces. Infect Immun 2001; 69:3423–3426 [View Article][PubMed]
    [Google Scholar]
  46. Fabretti F, Theilacker C, Baldassarri L, Kaczynski Z, Kropec A et al. Alanine esters of enterococcal lipoteichoic acid play a role in biofilm formation and resistance to antimicrobial peptides. Infect Immun 2006; 74:4164–4171 [View Article][PubMed]
    [Google Scholar]
  47. Tan LKK, Eccersley LRJ, Sriskandan S. Current views of haemolytic streptococcal pathogenesis. Curr Opin Infect Dis 2014; 27:155–164 [View Article][PubMed]
    [Google Scholar]
  48. Dmitriev AV, McDowell EJ, Chaussee MS. Inter- and intraserotypic variation in the Streptococcus pyogenes Rgg regulon. FEMS Microbiol Lett 2008; 284:43–51 [View Article][PubMed]
    [Google Scholar]
  49. Roberts AL, Connolly KL, Doern CD, Holder RC, Reid SD. Loss of the group A Streptococcus regulator Srv decreases biofilm formation in vivo in an otitis media model of infection. Infect Immun 2010; 78:4800–4808 [View Article][PubMed]
    [Google Scholar]
  50. Cole JN, Barnett TC, Nizet V, Walker MJ. Molecular insight into invasive group A streptococcal disease. Nat Rev Microbiol 2011; 9:724–736 [View Article][PubMed]
    [Google Scholar]
  51. Marouni MJ, Sela S. The luxS gene of Streptococcus pyogenes regulates expression of genes that affect internalization by epithelial cells. Infect Immun 2003; 71:5633–5639 [View Article][PubMed]
    [Google Scholar]
  52. Graham MR, Smoot LM, Migliaccio CA, Virtaneva K, Sturdevant DE et al. Virulence control in group A Streptococcus by a two-component gene regulatory system: global expression profiling and in vivo infection modeling. Proc Natl Acad Sci 2002; 99:13855–13860 [View Article][PubMed]
    [Google Scholar]
  53. Tatsuno I, Isaka M, Okada R, Zhang Y, Hasegawa T. Relevance of the two-component sensor protein CiaH to acid and oxidative stress responses in Streptococcus pyogenes . BMC Res Notes 2014; 7:189 [View Article][PubMed]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.001253
Loading
/content/journal/jmm/10.1099/jmm.0.001253
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error